Article thumbnail

Obstetrical Complications and Outcome in Two Families with Hereditary Angioedema due to Mutation in the F12 Gene

By Olivier Picone, Anne-Claire Donnadieu, François G. Brivet, Catherine Boyer-Neumann, Véronique Frémeaux-Bacchi and René Frydman

Abstract

Backgroud. Hereditary angioedema (HAE) is characterized by recurrent swelling of the skin, the abdomen (causing severe acute pain), and the airways. A recently discovered type caused by mutations in the factor XII gene (designated as HAE type III) occurs mainly in women. Estrogens may play an important role, but few obstetrical complications have been reported. Case. We report the symptoms and obstetrical complications of women in two families with HAE attributable to the p. Thr328Lys mutation in the F12 gene. Clinical manifestations included acute and severe maternal abdominal pain, with transient ascites, laryngeal edema, and fetal and neonatal deaths. Patients had normal C4 levels and a normal C1 inhibitor gene. Administration of C1-inhibitor concentration twice monthly decreased the attack rate in one mother, and its predelivery administration (1000 U) led to the delivery of healthy girls. Conclusions. Obstetricians and anesthesiologists should be aware of this rare cause of unexplained maternal ascites and in utero or fetal death associated with edema

Topics: Case Report
Publisher: Hindawi Publishing Corporation
OAI identifier: oai:pubmedcentral.nih.gov:2871183
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene,”BritishJournalofDermatology,vol.156,no.5,pp.1063– 1065,
  2. (2004). a r i m ,H .G r i ffiths, and S. Deacock, “Normal complement C4 values do not exclude hereditary angioedema,”
  3. (2000). and genetic characterization of a novel estrogen-dependent inherited form of angioedema,”
  4. (2008). Ayg¨ oren-P¨ urs¨
  5. (2002). Davis III, “Increased vascular permeability in C1 inhibitordeficient mice mediated by the bradykinin type 2 receptor,”
  6. (2005). Davis III, “The pathophysiology of hereditary angioedema,”
  7. (2006). Functional analysis of splicing mutations and of an exon 2 polymorphic variant of SERPING1/C1NH,”
  8. (2006). Hereditary angioedema managed with low-dose danazol and C1 esterase inhibitor concentrate: a case report,”
  9. (2007). Hereditary angioedema with normal C1 inhibitor gene in a family with affected women and men is associated with the p.Thr328Lys mutation in the F12 gene,”
  10. (2007). Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course,”
  11. (2000). Hereditary angioedema with normal C1-inhibitor activity in women,”
  12. Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large Spanish cohort,”
  13. (2006). Increased activity of coagulation factor XII (Hageman Factor) causes hereditary angioedema type III,”
  14. (2009). Kallikrein-kinin system and fibrinolysis in hereditary angioedema due to factorXIIgenemutationThr309Lys,”BloodCoagululationand Fibrinolysis,
  15. (2007). Mirror syndrome: a novel approach to therapy with fetal peritoneal-amniotic shunt,”
  16. (2006). Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor,”
  17. (1995). Molecular basis of estrogen regulation of Hageman factor XII gene expression,”
  18. (2006). o r k ,D .G ¨
  19. (2009). Recurrent European missense mutation in the F12 gene in a British family with type III hereditary angioedema,”
  20. (2007). Successful management with C1-inhibitor concentrate of hereditary angioedema attacks during two successive pregnancies: a case report,”
  21. (2007). T a r z i ,A .H i c k e y
  22. (2007). T.Bowen,M.Cicardi,K.Bork,etal.,“Hereditaryangioedema: a current state-of- the -art review,VII:canadian Hungarian
  23. (2001). Wolff,F .Z h a n g ,J .J .R o b e r g ,e ta l . ,“ E x p r e s s i o no fC 1 esterase inhibitor by the baculovirus expression vector system: preparation, purification, and characterization,” Protein Expression and Purification,
  24. (2009). Wulff,J .H a r d t ,G .W i t z k e ,a n dP .S t a u b a c h , “Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy,”